NCT00002423
Completed
Phase 2
A Phase II, Open-Label Trial for Treatment of HIV Infection in Subjects Who Have Failed Initial Combination Therapy With Regimens Containing Indinavir or Nelfinavir: Combination Therapy With 3TC (150 Mg BID), Abacavir (300 Mg BID) and Amprenavir (1200 Mg BID) Plus Either Nelfinavir (1250 Mg BID) or Indinavir (800 Mg TID) for 48 Weeks
Glaxo Wellcome8 sites in 1 country100 target enrollmentMarch 1999
ConditionsHIV Infections
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- HIV Infections
- Sponsor
- Glaxo Wellcome
- Enrollment
- 100
- Locations
- 8
- Status
- Completed
- Last Updated
- 20 years ago
Overview
Brief Summary
This study will compare the safety and effectiveness of two anti-HIV drug combinations in fighting HIV infection in patients whose viral loads (levels of HIV in the blood) rose with other anti-HIV drug treatments.
Detailed Description
Patients experiencing virologic failure while receiving an IDV-containing antiretroviral regimen will receive the 3TC/ABC/APV/NFV combination. Patients experiencing virologic failure while receiving an NFV-containing antiretroviral regimen will receive the 3TC/ABC/APV/IDV combination.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Study Sites (8)
Loading locations...
Similar Trials
Completed
Phase 2
A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment FailureHIV InfectionsNCT00000918National Institute of Allergy and Infectious Diseases (NIAID)300
Terminated
Phase 2
The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease InhibitorsHIV InfectionsNCT00002418Bristol-Myers Squibb25
Completed
Not Applicable
A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected PatientsHIV InfectionsNCT00002168Bristol-Myers Squibb200
Completed
Phase 1
Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV DrugsHIV InfectionsNCT00016718National Institute of Allergy and Infectious Diseases (NIAID)43
Completed
Phase 3
A Study to Compare Two Anti-HIV Drug CombinationsHIV InfectionsNCT00002447Hoffmann-La Roche146